Keyphrases
Blood-brain Barrier
83%
Alzheimer's Disease
79%
Endothelium
38%
125I
35%
Amyloid-β Peptide
31%
Amyloid Plaques
30%
Insulin
29%
Amyloid beta
28%
Alzheimer's Disease Model
23%
Amyloid Protein
21%
Cerebral Amyloid Angiopathy
18%
Alzheimer's Disease Brain
17%
Nanovehicles
16%
Endothelial Cells
14%
Insulin Signaling
14%
Intraneuronal
12%
Plaque
12%
Melatonin
12%
Mimetic Peptide
12%
High-density Lipoprotein Cholesterol (HDL-C)
12%
Cerebral Vasculature
12%
Neurodegeneration
11%
Endocytosis
11%
Alzheimer's Disease Pathology
10%
Amyloid Deposition
10%
Blood-brain Barrier Disruption
9%
Fluorescein
9%
Olfactory mucosa
9%
Contrast Agent
9%
Plasma Pharmacokinetics
9%
Scopolamine
8%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
8%
Gut Microbiota
8%
Antibody Fragment
8%
Plaque Targeting
8%
Transdermal Drug Delivery
8%
Vascular Cell Adhesion molecule-1 (VCAM-1)
8%
Bicelle
8%
Single-photon Emission Computed Tomography (SPECT)
7%
APPPS1
7%
Neurodegenerative Diseases
7%
Neuronal Uptake
7%
Brain Pharmacokinetics
7%
Hippocampal Neurons
7%
Alzheimer's Disease Patient
6%
Wild Mice
6%
Cerebrovascular Disease
6%
Neuronal Cells
6%
Transgenic Mice
6%
In Vitro Blood-brain Barrier Model
6%
Neuroscience
Alzheimer's Disease
100%
Amyloid Protein
82%
Blood Brain Barrier
74%
Iodine-125
32%
Blood Plasma
23%
Beta Amyloid
20%
Pharmacokinetics
20%
Amyloid Beta Protein
16%
Cerebral Amyloid Angiopathy
14%
Insulin Signaling
13%
Endocytosis
12%
High-Density Lipoprotein
12%
Contrast Medium
10%
Positron Emission Tomography
10%
In Vivo
9%
In Vitro
9%
Fluorescein
8%
Molecular Imaging
8%
Protein Kinase B
7%
Neurodegenerative Disorder
6%
Insulin Receptor
6%
Neurodegeneration
6%
Polyamine
6%
Amino Terminal Sequence
6%
Monoclonal Antibody
6%
Internalization
6%
Apolipoprotein A
5%
Magnetic Resonance Imaging
5%
Histidine
5%
Mouse Brain
5%
Computed Tomography
5%
Kinase
5%